Richard A. Lerner

President Emeritus at The Scripps Research Institute

Richard A. Lerner

Richard A. Lerner

President Emeritus at The Scripps Research Institute

Overview
Career Highlights

Zebra Biologics, Inc.
CovX Research LLC

RelSci Relationships

1741

Number of Boards

25

Birthday

1939 - Chicago, IL, United States

Age

81

Number of Awards

7

Contact Data
Trying to get in touch with Richard A. Lerner? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Richard A. Lerner likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer & Chairman of the Board at OPKO Health, Inc.

Relationship likelihood: Strong

Vice Chairman of the Board & Chief Technical Officer at OPKO Health, Inc.

Relationship likelihood: Strong

Co-Founder at Zebra Biologics, Inc.

Relationship likelihood: Strong

Co-Founder at REPLIGEN Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at The Scripps Research Institute

Relationship likelihood: Strong

Co-Founder at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Governor of the Minerva Academy at Minerva Project, Inc.

Relationship likelihood: Strong

Founding Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Co-Founder at Genentech, Inc.

Relationship likelihood: Strong

Consulting Professor, Department of Chemistry at Stanford University

Relationship likelihood: Strong

Paths to Richard A. Lerner
Potential Connections via
Relationship Science
You
Richard A. Lerner
President Emeritus at The Scripps Research Institute
Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Career History
President Emeritus
1986 - Current

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Co-Founder
Current

Zebra Biologics, Inc., a biotechnology company, discovers and develops biosuperior antibody therapeutics and complex drug targets. The company was founded in 2013 and is based in Concord, Massachusetts.

Founder
2002 - Prior

CovX Research LLC, a subsidiary of Pfizer Inc., is an American company located in San Diego, CA, that manufactures biotherapeutics and medical products. It was founded by Carlos F. Barbas and Richard Alan Lerner. CovX Research LLC was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on 31 Jan 08 for $230 million.

Boards & Committees
Director
2002 - Current
Trustee
Current
Board Member
2007 - 2007
Member, Biomedical Science Advisory Board
Current
Outgoing President
Prior
Political Donations
Investments
Details Hidden

CovX Research LLC, a subsidiary of Pfizer Inc., is an American company located in San Diego, CA, that manufactures biotherapeutics and medical products. It was founded by Carlos F. Barbas and Richard Alan Lerner. CovX Research LLC was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on 31 Jan 08 for $230 million.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2010
University of Warwick
2007
University of Oxford
2004
Florida Atlantic University
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard A. Lerner. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard A. Lerner's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard A. Lerner.